Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer

被引：0
|
作者：
David N. Danforth
JoAnne Zujewski
Joyce O'Shaughnessy
David Riseberg
Seth M. Steinberg
Nanette McAtee
Marianne Noone
Catherine Chow
Usha Chaudhry
Marc Lippman
Joan Jacobson
Paul Okunieff
Kenneth H. Cowan
机构：
[1] NCI,Surgery Branch
[2] National Cancer Institute,Medicine
[3] National Cancer Institute,Radiation Oncology
[4] National Cancer Institute,Branches, and the Biostatistics and Data Management Section
[5] Clinical Center,Department of Radiology
[6] National Institutes of Health,Department of Rehabilitation Medicine
[7] Clinical Center,undefined
[8] National Institutes of Health,undefined
来源：
Annals of Surgical Oncology | 1998年 / 5卷
关键词：
Neoadjuvant chemotherapy; Stage III breast cancer; Breast radiotherapy; Mastectomy; Inflammatory breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Stage IIIA,B breast cancer is commonly treated with neoadjuvant chemotherapy because of high objective response rates and improved operability. Criteria for subsequent selection of local therapy—mastectomy, radiotherapy, or both—are not well defined. We adopted a policy of selective local therapy based on rebiopsy of the breast and clinical axillary lymph node status at the time of best response to chemotherapy.
引用
收藏
页码：150 / 158
页数：8
相关论文
共 50 条
  • [1] Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer
    Danforth, DN
    Zujewski, J
    O'Shaughnessy, J
    Riseberg, D
    Steinberg, SM
    McAtee, N
    Noone, M
    Chow, C
    Chaudhry, U
    Lippman, M
    Jacobson, J
    Okunieff, P
    Cowan, KH
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (02) : 150 - 158
  • [2] Role of paclitaxel in neoadjuvant chemotherapy in stage IIA-IIIA breast cancer
    Schenker, M.
    Badulescu, F.
    Badulescu, A.
    Ionescu, M.
    Ninulescu, C.
    Crisan, A.
    Dinescu, S.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 284 - 284
  • [3] Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB
    Kim, R
    Osaki, A
    Tanabe, K
    Toge, T
    [J]. ONCOLOGY REPORTS, 2004, 11 (06) : 1265 - 1272
  • [4] Breast-conserving surgery after neoadjuvant chemotherapy for stage III breast cancer patients
    Shin, Hee-Chul
    Han, Wonshik
    Moon, Hyeong-Gon
    Moon, Woo Kyung
    Im, Seock-Ah
    Kim, Tae-You
    Park, In-Ae
    Noh, Dong-Young
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Feasibility of Breast Conserving Surgery in Stage IIIA Breast Carcinoma Patients in the Absence of Neoadjuvant Therapy
    Ibrahim, Abeer
    Amin, Anwar T.
    Hassan, Rehab
    [J]. MIDDLE EAST JOURNAL OF CANCER, 2015, 6 (03) : 157 - 164
  • [6] Local recurrence rates are low in Japanese breast cancer patients after neoadjuvant chemotherapy
    Shigekawa, T.
    Osaki, A.
    Ueda, S.
    Takeuchi, H.
    Hirokawa, E.
    Sugitani, I.
    Sugiyama, M.
    Shimada, H.
    Takahashi, T.
    Saeki, T.
    [J]. BREAST, 2015, 24 : S133 - S133
  • [7] Thoracoscopic radical resection in the treatment of NSCLC patients (stage IIIA) after neoadjuvant chemotherapy
    Zhao, Liang
    Zhang, Lingling
    Liu, Shubin
    Xu, Jie
    [J]. JOURNAL OF BUON, 2021, 26 (02): : 313 - 319
  • [8] Neoadjuvant chemotherapy in stage III breast cancer
    Alassas, M
    Chu, QY
    Burton, G
    Ampil, F
    Mizell, J
    Li, BD
    [J]. AMERICAN SURGEON, 2005, 71 (06) : 487 - 492
  • [9] Locoregional therapy in breast cancer patients treated with neoadjuvant chemotherapy
    Murchison, Sonja
    Truong, Pauline
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (08) : 865 - 875
  • [10] Breast-Conserving Surgery after Neoadjuvant Chemotherapy is Oncologically Safe for Stage III Breast Cancer Patients
    Shin, H-C
    Han, W.
    Moon, H-C
    Im, S-A
    Park, S-J
    Noh, D-Y
    [J]. CANCER RESEARCH, 2012, 72
12345